ANGELALIGN TECHNOLOGY INC(AGLFF)
USD --+0.00%
Reward61Moderate
Risk38Moderate
📊75%Data
Revenue growing 42% YoY
AGLFF
+0.0 · +0.00%
USD · PINK
ANGELALIGN TECHNOLOGY INC | Healthcare
Growth Machine
Market Cap:1.74Bn
ℹ️
Reward Rating
61
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
38
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on AGLFF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is ANGELALIGN TECHNOLOGY INC?

, an investment holding company, researches and designs, manufactures, sells, and markets clear aligner treatment solutions in the People's Republic of China and internationally.

AGLFF · Verdict

Solid reward · moderate risk

AGLFF stands out on cash flow and growth, but watch the valuation signal.

Based on 88% data coverage

AGLFF · Verdict

What’s working & what to watch

Strengths 2

  • Cash flow82/100

    14% free-cash-flow margin

  • Growth75/100

    Rev +26.2% CAGR · earnings -2.8%

Watchouts 1

  • Valuation39/100

    P/E 30.9×

Model-based scoring. For information only — not financial advice.

What is ANGELALIGN TECHNOLOGY INC?

, an investment holding company, researches and designs, manufactures, sells, and markets clear aligner treatment solutions in the People's Republic of China and internationally. The company's products include Angel Aligner Pro and Angel Aligner Select, a custom made removable clear orthodontic aligners that move the patient's teeth into the proper position over time; Angel Aligner KiD, a early orthodontic solution from prevention to treatment; and Angel Aligner Retainer. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.74B, and a P/E ratio of 59.9x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (61)

The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap1.74B
P/E Ratio59.8824
Dividend Yield0.61%
52 Week High10.18
52 Week Low7.1251
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding171M
No. of Employees4,312
IndustryMedical Instruments & Supplies
ExchangePINK
Beta1.151
CurrencyUSD